Future trends in infertility treatment: Challenges ahead

Fertility and Sterility

Volumn 68, Issue 6, 1997, Pages 977-980

  Lunenfeld, B ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Blastocyst transfer; Ethical aspects; GnRH antagonists; Infertility treatment; Recombinant gonadotropins

Indexed keywords

GONADOTROPIN; GROWTH FACTOR;

EDITORIAL; HEALTH SERVICE; INFERTILITY; NEOVASCULARIZATION (PATHOLOGY); PREMATURITY; PRIORITY JOURNAL; QUALITY OF LIFE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SPERMATOZOON; WORLD HEALTH ORGANIZATION;

EID: 0031437969     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00408-1     Document Type: Editorial

References (6)

1. FL Barnes A Kausche J Tiglias C Wood L Wilton A Trounson Production of embryos from in vitro matured primary human oocytes Fertil Steril 65 1996 1151 1156
2. M Lane DK Gardner Selection of viable blastocysts prior to transfer using metabolic criteria Hum Reprod 9 1996 1975 1978
3. P Braude V Boloton S Moore Human gene expression first occurs between the four- and eight-cell stages of preimplantation development Nature 332 1988 459
4. R Agrawal First pregnancy using three recombinant gonadotrophins Lancet 9044 1997 29 30
5. K Dietrich R Felberbaum Multiple dose protocol for the administration of GnRH-antagonist in IVF: the Luebeck Protocol J Assist Reprod Genet 14 supplement 15S 1997 PS-072 (abstract)
6. F Oliviennes PH Bouchard R Frydman The use of new GnRH antagonist (Cetrorelix) with a single dose protocol in IVF J Assist Reprod Genet 14 suppl 15S 1997 PS-07-2 (abstract)